Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey

Author:

Badgery Henry E.ORCID,Muhlen-Schulte Tjuntu,Zalcberg John R.ORCID,D'souza Bianka,Gerstenmaier Jan F.,Pickett CraigORCID,Samra Jaswinder,Croagh DanielORCID,Ahmed Farhan,Allan Emel,Amelina Inna,Aroori Somaiah,Balendran Nalayini,Ban Ee J.,Bartlett DavidORCID,Berry Roger,Bezuidenhout AbrahamORCID,Bhogal Ricky,Bolan Candice,Bolm LouisaORCID,Bonifacio CristianaORCID,Borsaru Adina,Burnett David,Butterfield NickORCID,Cannella RobertoORCID,Capretti GiovanniORCID,Carnelli Carlos,Chatzizacharias Nikolaos,Chingoli Felix,Chu Linda,Chu Wai pongORCID,Clark ToshimasaORCID,Connor SaxonORCID,Currin Stephen,Daruwalla JurstineORCID,De Santis DomenicoORCID,Dhawan Ankita,Di Muzio BrunoORCID,Dioguardi Burgio MarcoORCID,Dunn Joel,Gemenetzis GeorgiosORCID,Goodwin MarkORCID,Gray AndrewORCID,Halloran ChristopherORCID,Harisis GeorgeORCID,Harris Heather,He Jin,Hecht ElizabethORCID,Heumann Asmus,Hodgson RussellORCID,Hui CathrynORCID,Kalinin Petr,Kleeff Jorg,Ko Hyun S.ORCID,Kozyreva Ksenia,Kutaiba NumanORCID,Lewin JoelORCID,Lim ChristopherORCID,Lohöfer Fabian,Loveday Benjamin,Marchegiani GiovanniORCID,Mastrocostas KaterinaORCID,Mavroeidis Vasileios K.,Merrett NeilORCID,Nebbia Martina,Neoptolemos JohnORCID,Nesterov Denis,Pilgrim Charles,Reames Bradley N.ORCID,Rowcroft AlistairORCID,Seale Melanie,Siddique Sabbir,Smith MartyORCID,Sugrue Gavin,Thakur Jatin,Thomas RoseORCID,Tibermacine WalidORCID,Tolat ParagORCID,Triantopoulou Charikleia,Trofimov StanislavORCID,Uzunoglu Faik G.ORCID,Vernuccio Federica,De Boo Diederick W.ORCID,Webber LaurenceORCID,Wei AliceORCID,Wood VerityORCID,Zins MarcORCID

Funder

PanKind, The Australian Pancreatic Cancer Foundation

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Pancreatic cancer;Mizrahi;Lancet,2020

2. Cancer statistics, 2022;Siegel;Ca - Cancer J Clin,2022

3. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study;Arnold;Lancet Oncol,2019

4. Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy;Christians;Surgery,2016

5. Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience;Malik;J Gastrointest Oncol,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3